Regeneron and Roche Await Data On Potential COVID-19 Blockbuster

Early Signs Of Efficacy Expected In September

 
• By Andrew McConaghie
  
Antibodies
Monoclonal antibody therapies could mimic the body's own defenses against SARS-CoV-2 virus - but act faster, and help block infection
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip